B. John Lindeman - 28 May 2026 Form 4 Insider Report for CALAVO GROWERS INC (CVGW)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CVGW
Reported as of: 28 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 21:34:05 UTC
Prior SEC filing: 27 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ B. John Lindeman

Key filing fact

B. John Lindeman filed Form 4 for CALAVO GROWERS INC (CVGW) on 28 May 2026.

Key facts

This page summarizes B. John Lindeman's Form 4 filing for CALAVO GROWERS INC (CVGW).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 28 May 2026, 21:34.

Change

Previous filing in this sequence was filed on 27 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001649692 Primary reporting owner

Lindeman Bruce John

Relationship: Chief Executive Officer, Director
Address: C/O CALAVO GROWERS, INC., 1141-A CUMMINGS RD., SANTA PAULA
Signature: /s/ B. John Lindeman
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVGW transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -24,556
Change %: -100%
Price
Shares after: 0
Date: 28 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVGW transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -2,200
Change %: -100%
Price: $27.69^*
Shares after: 0
Date: 28 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,200
Exercise price
Footnotes: F2, F3

CVGW transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -10,000
Change %: -100%
Price: $1.85^*
Shares after: 0
Date: 28 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $25.84
Footnotes: F4, F5

CVGW transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -100,000
Change %: -100%
Price: $7.36^*
Shares after: 0
Date: 28 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $20.33
Footnotes: F4, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

B. John Lindeman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

The shares were disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 14, 2026, by and among Calavo Growers, Inc. ("Calavo") Mission Produce, Inc. ("Mission Produce"), Cantaloupe Merger Sub I, Inc. and Cantaloupe Merger Sub II, LLC. Pursuant to the Merger Agreement, at the First Effective Time (as defined in the Merger Agreement), each share of common stock, par value $0.001 per share, of Calavo ("Calavo Common Stock") was converted into the right to receive (i) 0.9790 shares of common stock, par value $0.001 per share, of Mission Produce and cash in lieu of fractional shares and (ii) $14.85 in cash, without interest.

Footnote F2

Pursuant to the Merger Agreement, each restricted stock unit constituting a Deferred RSU (as defined in the Merger Agreement), was cancelled at the First Effective Time and converted into a right to receive an amount in cash, without interest, equal to the product obtained by multiplying (a) the number of shares of Calavo Common Stock underlying the Deferred RSU, by (b) the merger consideration value of $27.69.

Footnote F3

The restricted stock units fully vested on April 23, 2025, and the reporting person's receipt of 2,200 shares of common stock was deferred pursuant to the restricted stock unit award agreement between the reporting person and Calavo.

Footnote F4

Pursuant to the Merger Agreement, each outstanding and unexercised stock option, whether or not vested or exercisable, was cancelled at the at the First Effective Time and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying (a) the number of shares of Calavo Common Stock underlying such stock option, by (b) the excess, if any, of the merger consideration value of $27.69 over the exercise price per share of Calavo Common Stock applicable to the stock option, less any applicable tax withholding.

Footnote F5

Subject to footnote (4), the stock option vests in equal increments on each anniversary date of the grant on June 3, 2024 over a five-year period, and each increment is exercisable for five years from its vesting date.

Footnote F6

Subject to footnote (4), 25% of the shares underlying the stock option are fully vested as of December 8, 2025, and the remainder of the shares underlying the stock option vest in three equal annual installments over the subsequent three years subject to the Reporting Person's continuous service with Calavo as of each vesting date.